BACKGROUND: Photodynamic therapy (PDT) is recommended for both lesion and field therapy of actinic keratoses (AKs). The 5-amino-laevulinic acid (5-ALA) patch PDT is indicated for the treatment of isolated mild AKs (≤1.8 cm) on the face and bald scalp. It was demonstrated to be effective and safe in clinical trials with a good tolerability profile. METHODS: In this retrospective multicenter real-life study, 33 patients with a total of 99 AKs of the scalp, face, ears, and/or hands and 2 actinic cheilitis were treated with one treatment session of 5-ALA patch PDT with a red light source (total dose of 37 J/cm2). RESULTS: Overall, 12 weeks after treatment, 68/99 (69%) lesions were completely cleared. Complete response was obtained in 82% of AKs on the ears, 78% on the face, 57% on the hands, and 56% on the scalp and in the two actinic cheilitis. The treatment was very effective on grade I AKs, cleared in 87% of the cases and less efficient on grade II–III lesions, cleared in 47% of the cases. 5-ALA patch PDT was well tolerated with a good to excellent cosmetic outcome in 97% of the patients and with 94% of the patients being satisfied or very satisfied with the treatment. CONCLUSIONS: Our results confirm that 5-ALA patch PDT is a good option for AK treatment in clinical practice, it is easy to use, effective and well tolerated even in difficult-to-treat-areas. Moreover, it has an excellent cosmetic outcome.

5-Aminolaevulinic acid patch photodynamic therapy for the treatment of actinic keratoses. preliminary results from an Italian study in the real-life setting / Dattola, Annunziata; Gutiérrez Garcìa-Rodrigo, Carlota; Tambone, Sara; Garofalo, Virginia; Lappi, Astrid; De Luca, Erika V; Peris, Ketty; Bianchi, Luca; Campione, Elena; Fargnoli, Maria C. - In: GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA. - ISSN 1827-1820. - 155:5(2020), pp. 636-641. [10.23736/S0392-0488.20.06598-0]

5-Aminolaevulinic acid patch photodynamic therapy for the treatment of actinic keratoses. preliminary results from an Italian study in the real-life setting

Dattola, Annunziata
Primo
Writing – Original Draft Preparation
;
De Luca, Erika V;
2020

Abstract

BACKGROUND: Photodynamic therapy (PDT) is recommended for both lesion and field therapy of actinic keratoses (AKs). The 5-amino-laevulinic acid (5-ALA) patch PDT is indicated for the treatment of isolated mild AKs (≤1.8 cm) on the face and bald scalp. It was demonstrated to be effective and safe in clinical trials with a good tolerability profile. METHODS: In this retrospective multicenter real-life study, 33 patients with a total of 99 AKs of the scalp, face, ears, and/or hands and 2 actinic cheilitis were treated with one treatment session of 5-ALA patch PDT with a red light source (total dose of 37 J/cm2). RESULTS: Overall, 12 weeks after treatment, 68/99 (69%) lesions were completely cleared. Complete response was obtained in 82% of AKs on the ears, 78% on the face, 57% on the hands, and 56% on the scalp and in the two actinic cheilitis. The treatment was very effective on grade I AKs, cleared in 87% of the cases and less efficient on grade II–III lesions, cleared in 47% of the cases. 5-ALA patch PDT was well tolerated with a good to excellent cosmetic outcome in 97% of the patients and with 94% of the patients being satisfied or very satisfied with the treatment. CONCLUSIONS: Our results confirm that 5-ALA patch PDT is a good option for AK treatment in clinical practice, it is easy to use, effective and well tolerated even in difficult-to-treat-areas. Moreover, it has an excellent cosmetic outcome.
2020
actinic; dermatology; keratosis; photochemotherapy
01 Pubblicazione su rivista::01a Articolo in rivista
5-Aminolaevulinic acid patch photodynamic therapy for the treatment of actinic keratoses. preliminary results from an Italian study in the real-life setting / Dattola, Annunziata; Gutiérrez Garcìa-Rodrigo, Carlota; Tambone, Sara; Garofalo, Virginia; Lappi, Astrid; De Luca, Erika V; Peris, Ketty; Bianchi, Luca; Campione, Elena; Fargnoli, Maria C. - In: GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA. - ISSN 1827-1820. - 155:5(2020), pp. 636-641. [10.23736/S0392-0488.20.06598-0]
File allegati a questo prodotto
File Dimensione Formato  
Dattola_5-Aminolaevulinic_2020.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 4.72 MB
Formato Adobe PDF
4.72 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1733918
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact